Given that TAM suppresses CD8+ T-cell proliferation and activation, thereby facilitating HCC progression [14, 15], we hypothesized that SENP3-mediated immunosuppression in HCC may act through TAM. The gene discussed is SENP3; the disease is hepatocellular carcinoma.